4.4 Review

Immunization During Pregnancy: Impact on the Infant

期刊

PEDIATRIC DRUGS
卷 19, 期 4, 页码 313-324

出版社

ADIS INT LTD
DOI: 10.1007/s40272-017-0231-7

关键词

-

资金

  1. GlaxoSmithKline
  2. Novartis
  3. Pfizer
  4. Novavax
  5. MedImmune
  6. National Health and Medical Research Council Early Career Fellowship [APP1054394]
  7. MCRI Career Development Award

向作者/读者索取更多资源

Maternal immunization has undergone a paradigm shift in recent years, as women and healthcare providers accept and recognize the benefits of this strategy not only for the pregnant woman but also for the developing fetus and young infant. This article reviews the evidence for active immunization during pregnancy, with an emphasis on perinatal and infant outcomes. Current recommendations for immunization during pregnancy are presented, with particular focus on the routinely recommended vaccines during pregnancy: influenza and Tdap (tetanus, diphtheria, and pertussis). We discuss future research directions, maternal vaccines in development, and considerations for optimizing and advancing this underutilized strategy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据